期刊文献+

牛乳铁蛋白活性多肽LfcinB在大肠杆菌中的串联表达、纯化及生物活性分析 被引量:4

Tandem Expression,Purification and Bioactivity Characterization of Bovine Lactoferricin Peptide in Escherichia coli
下载PDF
导出
摘要 牛乳铁蛋白(LfcinB)是一种阳离子抗菌肽,具有抗细菌、抗肿瘤等多种生物学活性.本文探讨了利用SUMO(Small Ubiquitin-Related Modifier)融合标签在大肠杆菌系统中通过LfcinB串联表达策略制备重组LfcinB的方法.结果显示,大于90%的SUMO-(LfcinB)n蛋白以可溶形式表达于BL21(DE3)细胞中;SUMO-(LfcinB)2的表达量高于SUMO-LfcinB和SUMO-(LfcinB)3.通过SUMO特异性蛋白酶切除SUMO标签,羟胺释放单体,得到纯化的重组LfcinB,产率约为15 mg/L.生物活性结果表明,重组LfcinB具有一定的抗菌和抗肿瘤活性.本研究为结合SUMO标签与串联表达策略大量制备获得具有生物学功能的重组抗菌肽提供了一种有效的方法. Bovine lactoferricin(LfcinB)is a cationic antimicrobial peptides with activities of anti-bacteria and anti-tumor. Here it was reported that a method of producing tandem multimers of LfcinB using SUMO(small ubiquitin-related modifier)tag in Escherichia coli. Results showed that the expression level of the soluble fusion protein with SUMO tag was more than 90% of total target protein,and the dimer of LfcinB was expressed at a higher level than monomer and trimer when fused with SUMO tag. After using SUMO-specific protease to remove the SUMO tag,hydroxylamine to release monomer,the purified LfcinB was obtained with a yield of approximately 15 mg/L. The biological assays demonstrated that the recombinant LfcinB exhibited a certain antimicrobial and antitumor activity. Altogether,the SUMO fusion system with tandem repeat expression technology provides a potential production method for functional antimicrobial peptides.
作者 刘珂杭 宗西翠 张慧丹 完颜杨珂 陈玉清 Liu Kehang;Zong Xicui;Zhang Huidan;Wanyan Yangke;Chen Yuqing(School of Life Sciences,Nanjing Normal University,Institute of Biochemistry and Biological Products,Nanjing 210023,China;Department of Basic Western Medicine,Nanjing University of Chinese Medicine Hanlin College,Taizhou 225300,China)
出处 《南京师大学报(自然科学版)》 CAS CSCD 北大核心 2020年第2期100-107,共8页 Journal of Nanjing Normal University(Natural Science Edition)
基金 国家自然科学基金项目(81573337) 江苏省自然科学基金项目(BK20141446).
关键词 Bovine lactoferricin 抗菌肽 串联表达 SUMO Bovine lactoferricin antimicrobial peptide tandem expression SUMO
  • 相关文献

参考文献1

二级参考文献14

  • 1姚玲玲,王家宁,黄永章,郭凌郧.利用同尾酶技术构建pET15b-PEP-1-CAT重组质粒[J].郧阳医学院学报,2006,25(1):1-5. 被引量:9
  • 2杨涛,杨利军,程牛亮,解军,张悦红,牛勃.一种构建多拷贝串联小分子多肽基因的方法[J].生物技术通讯,2006,17(2):204-206. 被引量:3
  • 3Feng Y,Bfoder CC,Kcnnedy PE,et al.HIV-l enlry cofactor:functlonalcDNA cIoning of a seven transmembrane,G protein-coupled feceptor[J].Scicnce,1996,272:872-877.
  • 4Alkhatib G,Combadiere C,Broder CC,et al.CC CKR5:a RANTES,MIP 1 alpha,MIP-1 beta receptor as a fusion cofactor formacrophage-tropic HIV-1[J].Science,l 996,272:19S5-1958.
  • 5Choe H,Farzan M,Sun Y,et al.The beta-chemokine receptors CCR3and CCR5 facilitate infection by primary HIV-1 isolates[J].Cell,1096,85:1135-1148.
  • 6Menten P,Wuyts A,Van Darmne J.Macrophage inflammatory pro-tein-1[J].Cytokine Growth Factor Rev,2002,13(6):455-481.
  • 7Zlotnik A,Yoshie O.Chemokines:a new classification system andtheir role in immunity[J].Immunity,2000,12(2):121-127.
  • 8Modi W S.CCL3L1 and CCL4L1 chemokine genes are located in asegmental duplication at chromosome 17q121[J].Genomics,2004,83(4):735-738.
  • 9O'Brien SJ,Nelson GW.Human genes that limit AIDS[J].Nature ge-netics,2004,36,565-574.
  • 10Charles R.CCL3L1 dose and HIV-1 susceptibility[J].Trends inMolecular Medicine,2005,11(5):203-206.

共引文献3

同被引文献47

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部